Cybin Cybin is a biopharmaceutical company that focuses on developing psychedelic-based therapeutics. | |||
Founding Date | Founding Date 2019 | Founding Date 1915 | Founding Date 1978 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Toronto, CA HQ Dublin, IE | Locations København, DK HQ Buenos Aires, AR North Ryde, AU Wien, AT Bruxelles, BE Rio De Janeiro, BR Sofia, BG see more | Locations HQ |
Employees | Employees 50 | Employees 5,700 | Employees 52 |
Valuation ($) | Valuation ($) 209.9 m | Valuation ($) 6.2 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) kr24.6b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods kr2.7b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit kr22b (FY, 2025) | Gross profit N/A |
Net income | Net income ($113.1m) (FY, 2025) | Net income kr3.2b (FY, 2025) | Net income N/A |
Operating ⚠ | |||
Trademarks | Trademarks 24 (FY, 2023) | Trademarks 2.7 k (May, 2024) | Trademarks N/A |

H. Lundbeck is a pharmaceutical company specializing in brain diseases.
View company